At what growth rate will the market be projected to grow during the forecast period of 2022 to 2029?

The Needle Biopsy Market is projected to grow at a CAGR of 4.2% during the forecast period by 2028. Read More

What will be the market value in the future?

The future market value of the Needle Biopsy Market is expected to reach USD 154.18 million by 2028. Read More

Who are the major players operating in the market?

The major players in the Needle Biopsy Market are Nouryon, Solvay, Evonik Industries AG, Global Amines, Kao Corporation, Procter & Gamble, Arkema, Ecogreen Oleochemicals, Indo Amines Limited., NOF CORPORATION, TIANYU OIL., etc. Read More

Which countries data are covered in the report?

The countries covered in the Needle Biopsy Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, etc. Read More

Needle Biopsy Market Size, Growth & Future Scope to 2028

Global Needle Biopsy Market, By Needle Type (Trephine Biopsy Needles, Klima Sternal Needle, Salah Needle Aspiration Needle, Jamshidi Needle and Others), Ergonomics (Sharp, Blunt, Quincke, Chiba, Franseen and Others), Procedure (Fine-Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Image-Guided Biopsy), Sample Site (Muscles, Bones and Other Organs), Utility (Disposable and Reusable), Application (Tumour, Infection, Inflammation and Others), End User (Hospitals, Diagnostic Centres, Biopsy Labs, Ambulatory Surgical Centres, Academic and Research Organizations and Others), Distribution Channel (Direct Tender, Retail Sales), Country (U.S., Canada, Mexico, Germany, France, U.K., Belgium, Lithuania, Austria, Ireland, Norway, Poland, Italy, Spain, Russia, Turkey, Netherlands Switzerland, Rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel and Rest of Middle East and Africa) Industry Trends and Forecast to 2028.

Market Analysis and Insights: Global Needle Biopsy Market

The needle biopsy market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.2% in the forecast period of 2021 to 2028 and is expected to reach USD 154.18 million by 2028. Increased prevalence of breast cancer and lung cancer is expected to drive the global needle biopsy market.

A needle biopsy is a manual, image-guided or ultrasound procedure used to obtain a sample of cells from the human body for laboratory or diagnostic testing, especially of the tumour. The common needle biopsy procedures include fine-needle aspiration biopsy and core needle biopsy. When a doctor identifies an abnormal lump or when the imaging scans show abnormalities in the body, then needle biopsy comes in place.

The rise in government initiatives and organizations is projected to drive the global needle biopsy market’s growth. The increased cost of needle biopsies is expected to hinder the global needle biopsy market growth. The increase in research and development activities will pave the way for lucrative opportunities for the global needle biopsy market. The stringent rules and regulations are expected to pose as a challenge for the global needle biopsy market.

The needle biopsy market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the global needle biopsy market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Needle Biopsy Market Scope and Market Size

The needle biopsy market is segmented on the basis of the needle type, ergonomics, procedure, sample site, utility, application, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

On the basis of needle type, the needle biopsy market is segmented into trephine biopsy needles, klima sternal needle, salah needle aspiration needle, jamshidi needle and others. In 2021, the trephine biopsy needles segment is expected to dominate the needle biopsy market due to its overall assessment of morphology and it is used as an alternative to fine needle biopsy.

On the basis of ergonomics, the needle biopsy market is segmented into sharp, blunt, quincke, chiba, franseen and others. In 2021, the sharp segment is expected to dominate the needle biopsy market due to its accurate detection and diagnosis of the cancer tumour.

On the basis of procedure, the needle biopsy market is segmented into fine-needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy and image-guided biopsy. In 2021, the fine-needle aspiration biopsy segment is expected to dominate the needle biopsy market since its minimally invasive.

On the basis of sample site, the needle biopsy market is segmented into muscles, bones and other organs. In 2021, the muscles segment is expected to dominate the needle biopsy market, since it provides the source of the disease process and a better diagnostic.

On the basis of utility, the needle biopsy market is segmented into disposable and reusable. In 2021, the disposable segment is expected to dominate the needle biopsy market since the needle biopsy can be used once and disposed of carefully and the chances of infection are less.

On the basis of application, the needle biopsy market is segmented into tumour, infection, inflammation and others. In 2021, the tumour segment is expected to dominate the needle biopsy market due to increased malignant tumour cases in breast cancer and lung cancer and ease of localization and detection.

On the basis of end user, the needle biopsy market is segmented into hospitals, diagnostic centres, biopsy labs, ambulatory surgical centres, academic and research organizations and others. In 2021, the hospitals segment is expected to dominate the needle biopsy market due to the increased need for lymphangioleiomyomatosis and the availability of needle biopsy to dominate the market.

On the basis of distribution channel, the needle biopsy market is segmented into direct tender and retail sales. In 2021, direct tender segment is expected to dominate the needle biopsy market due to the rise in access to fine-needle aspiration biopsies, the surge in the number of biopsies daily and the rise in the number of contacts for the supply of diagnostic medications and needle biopsy.

Global Needle Biopsy Market Country Level Analysis

Global needle biopsy market is analysed and market size information is provided by the country, needle type, ergonomics, procedure, sample site, utility, application, end user and distribution channel as referenced above.

The countries covered in the global needle biopsy market report are the U.S., Canada, Mexico, Germany, France, U.K., Belgium, Lithuania, Austria, Ireland, Norway, Poland, Italy, Spain, Russia, Turkey, Netherlands Switzerland, rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel and rest of Middle East and Africa.

North America is expected to dominate due to the presence of the largest consumer market with high GDP due to the presence of major market players and rise in clinical trials in the region. The U.S. is dominating the North America needle biopsy market due to presence of FDA approvals and rise in technological advancements in needle biopsy and rise in breast cancer cases in women rise in elderly population. The fine-needle aspiration biopsy segment is dominating the U.S., since it’s cost effective and ensures accurate treatment in the U.S. patients. Whereas, Germany is expected to dominate in the Europe needle biopsy market due to presence of untapped opportunities in Germany for needle biopsy and presence of cancer research institutes in Germany. The fine-needle aspiration biopsy segment is expected to dominate the market due to increased preference for minimally invasive method. Additionally, China is expected to dominate the Asia-Pacific needle biopsy market due to increased awareness regarding the treatment for cancer and favourable reimbursement scenario for needle biopsy in China. The fine-needle aspiration biopsy segment is expected to dominate the market due to improvement in healthcare architecture in China and collaborations between healthcare organizations and market players.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Growth Potential for Needle Biopsy in Emerging Economies and Strategic Initiatives by Market Players are creating new Opportunities in the Global Needle biopsy Market

The needle biopsy market also provides you with detailed market analysis for every country growth in particular industry with needle biopsy sales, impact of advancement in the needle biopsy and changes in regulatory scenarios with their support for the needle biopsy market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Global Needle Biopsy Market Share Analysis

The needle biopsy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the global needle biopsy market.

The major companies covered in the global needle biopsy market report are Medax SRL, Boston Scientific Corporation, Cook, Hologic, Inc., ST. STONE MEDICAL DEVICES PVT. LTD., AprioMed AB, Amecath, Zamar Care, Cardinal Health, INRAD, Inc., BD, Möller Medical GmbH, HAKKO Corporation, ARGON MEDICAL, Merit Medical Systems, weLLgo Medical Products GmbH, Swastik Enterprise, Tsunami Medical Srl, Pajunk, B. Braun Melsungen AG among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product developments are also initiated by the companies worldwide which are also accelerating the growth of needle biopsy market.

For instance,

In January 2021, Hologic, Inc. acquired SOMATEX Medical Technologies GmbH, a leader in biopsy site biomarkers, for USD 64.00 million. The acquisition funds Hologic, Inc. strategy to deliver a varied range of novel solutions for the treatment of breast cancer. Hologic, Inc. would be able to expand the breast cancer marker portfolio.

Partnership, joint ventures and other strategies enhances the company market share with increased coverage and presence. It also provides the benefit for organisation to improve their offering for needle biopsy through expanded range of size.

SKU-36643

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Global Needle Biopsy Market – Industry Trends and Forecast to 2028

Market Analysis and Insights: Global Needle Biopsy Market

Needle Biopsy Market Scope and Market Size

Global Needle Biopsy Market Country Level Analysis

Competitive Landscape and Global Needle Biopsy Market Share Analysis

Please fill in the below form for Infographics

Research Methodology:

Please fill in the below form for Research Methodology

Customization Available:

Please fill in the below form for Available Customization

Frequently Asked Questions

At what growth rate will the market be projected to grow during the forecast period of 2022 to 2029?

What will be the market value in the future?

Who are the major players operating in the market?

Which countries data are covered in the report?

Browse Related Reports

Browse Related Blogs

Browse Related Press Release

FOLLOW US ON

REPORTS

MARKET INSIGHT

SUPPORT

SOLUTIONS